Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications.

Fornaro M, Anastasia A, Novello S, Fusco A, Pariano R, De Berardis D, Solmi M, Veronese N, Stubbs B, Vieta E, Berk M, de Bartolomeis A, Carvalho AF.

Pharmacol Res. 2018 Oct 29. pii: S1043-6618(18)31201-5. doi: 10.1016/j.phrs.2018.10.025. [Epub ahead of print] Review.

PMID:
30385364
2.

The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior.

Giza JI, Kim J, Meyer HC, Anastasia A, Dincheva I, Zheng CI, Lopez K, Bains H, Yang J, Bracken C, Liston C, Jing D, Hempstead BL, Lee FS.

Neuron. 2018 Sep 19;99(6):1356. doi: 10.1016/j.neuron.2018.08.041. No abstract available.

3.

The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention.

Fornaro M, De Berardis D, Anastasia A, Novello S, Fusco A, Cattaneo CI, Solmi M, Monaco F, Veronese N, Kim YK, de Bartolomeis A.

Psychiatry Res. 2018 Nov;269:658-672. doi: 10.1016/j.psychres.2018.08.034. Epub 2018 Aug 16. Review.

PMID:
30216918
4.

Pharmacological management of depression in patients with multiple sclerosis.

Carta MG, Paribello P, Anastasia A, De Berardis D, Nardi AE, Fornaro M.

Expert Opin Pharmacother. 2018 Oct;19(14):1533-1540. doi: 10.1080/14656566.2018.1516207. Epub 2018 Sep 12. Review.

PMID:
30207800
5.

Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors.

D'Urso G, Anastasia A, Toscano E, Patti S, de Bartolomeis A.

Exp Clin Psychopharmacol. 2018 Oct;26(5):509-513. doi: 10.1037/pha0000219. Epub 2018 Jul 23.

PMID:
30035575
6.

Soluble stroma-related biomarkers of pancreatic cancer.

Resovi A, Bani MR, Porcu L, Anastasia A, Minoli L, Allavena P, Cappello P, Novelli F, Scarpa A, Morandi E, Falanga A, Torri V, Taraboletti G, Belotti D, Giavazzi R.

EMBO Mol Med. 2018 Aug;10(8). pii: e8741. doi: 10.15252/emmm.201708741.

7.

The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior.

Giza JI, Kim J, Meyer HC, Anastasia A, Dincheva I, Zheng CI, Lopez K, Bains H, Yang J, Bracken C, Liston C, Jing D, Hempstead BL, Lee FS.

Neuron. 2018 Jul 11;99(1):163-178.e6. doi: 10.1016/j.neuron.2018.05.024. Epub 2018 Jun 14. Erratum in: Neuron. 2018 Sep 19;99(6):1356.

PMID:
29909994
8.

Pharmacological Cyclophilin Inhibitors Prevent Intoxication of Mammalian Cells with Bordetella pertussis Toxin.

Ernst K, Eberhardt N, Mittler AK, Sonnabend M, Anastasia A, Freisinger S, Schiene-Fischer C, Malešević M, Barth H.

Toxins (Basel). 2018 May 1;10(5). pii: E181. doi: 10.3390/toxins10050181.

9.

Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants.

Fornaro M, Anastasia A, Monaco F, Novello S, Fusco A, Iasevoli F, De Berardis D, Veronese N, Solmi M, de Bartolomeis A.

J Affect Disord. 2018 Jul;234:131-138. doi: 10.1016/j.jad.2018.02.085. Epub 2018 Mar 1.

PMID:
29525354
10.

Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis.

Fornaro M, Anastasia A, Novello S, Fusco A, Solmi M, Monaco F, Veronese N, De Berardis D, de Bartolomeis A.

Bipolar Disord. 2018 May;20(3):195-227. doi: 10.1111/bdi.12612. Epub 2018 Feb 14. Review.

PMID:
29441650
11.

Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician's perspective.

Fornaro M, Kardash L, Novello S, Fusco A, Anastasia A, De Berardis D, Perna G, Carta MG.

Expert Opin Drug Discov. 2018 Mar;13(3):221-228. doi: 10.1080/17460441.2018.1428554. Epub 2018 Jan 22.

PMID:
29357703
12.

Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.

Marzagalli M, Moretti RM, Messi E, Marelli MM, Fontana F, Anastasia A, Bani MR, Beretta G, Limonta P.

Sci Rep. 2018 Jan 12;8(1):587. doi: 10.1038/s41598-017-19057-4.

13.

Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients.

Fornaro M, Iasevoli F, Novello S, Fusco A, Anastasia A, De Berardis D, Valchera A, de Bartolomeis A.

J Affect Disord. 2018 Mar 1;228:118-124. doi: 10.1016/j.jad.2017.12.009. Epub 2017 Dec 7.

PMID:
29245092
14.

NMR backbone resonance assignments of the prodomain variants of BDNF in the urea denatured state.

Wang J, Bains H, Anastasia A, Bracken C.

Biomol NMR Assign. 2018 Apr;12(1):43-45. doi: 10.1007/s12104-017-9777-0. Epub 2017 Sep 20.

PMID:
28933046
15.

Transcranial Magnetic Stimulation as an Additional Diagnostic Tool in Children with Acute Inflammatory Demyelinating Polyneuropathy.

Voitenkov VV, Andrey K, Natalia S, Anastasia A.

J Pediatr Neurosci. 2017 Apr-Jun;12(2):144-148. doi: 10.4103/jpn.JPN_128_16.

16.

Hsp70 facilitates trans-membrane transport of bacterial ADP-ribosylating toxins into the cytosol of mammalian cells.

Ernst K, Schmid J, Beck M, Hägele M, Hohwieler M, Hauff P, Ückert AK, Anastasia A, Fauler M, Jank T, Aktories K, Popoff MR, Schiene-Fischer C, Kleger A, Müller M, Frick M, Barth H.

Sci Rep. 2017 Jun 2;7(1):2724. doi: 10.1038/s41598-017-02882-y.

17.

The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.

Sacco A, Fenotti A, Affò L, Bazzana S, Russo D, Presta M, Malagola M, Anastasia A, Motta M, Patterson CJ, Rossi G, Imberti L, Treon SP, Ghobrial IM, Roccaro AM.

Oncotarget. 2017 May 23;8(21):35435-35444. doi: 10.18632/oncotarget.16130. Review.

18.

Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study.

Pata G, Bartoli M, Damiani E, Solari S, Anastasia A, Pagani C, Tucci A.

Int J Surg. 2017 May;41:143-149. doi: 10.1016/j.ijsu.2017.03.077. Epub 2017 Mar 30.

PMID:
28366762
19.

Growth factors and hormones pro-peptides: the unexpected adventures of the BDNF prodomain.

Zanin JP, Unsain N, Anastasia A.

J Neurochem. 2017 May;141(3):330-340. doi: 10.1111/jnc.13993. Epub 2017 Mar 21. Review.

20.

Novel Drugs in Follicular Lymphoma.

Anastasia A, Rossi G.

Mediterr J Hematol Infect Dis. 2016 Nov 1;8(1):e2016061. eCollection 2016. Review.

21.

Transcranial direct current stimulation for obsessive-compulsive disorder: A randomized, controlled, partial crossover trial.

D'Urso G, Brunoni AR, Mazzaferro MP, Anastasia A, de Bartolomeis A, Mantovani A.

Depress Anxiety. 2016 Dec;33(12):1132-1140. doi: 10.1002/da.22578. Epub 2016 Nov 1.

PMID:
27802585
22.

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.

Santoro A, Mazza R, Pulsoni A, Re A, Bonfichi M, Zilioli VR, Salvi F, Merli F, Anastasia A, Luminari S, Annechini G, Gotti M, Peli A, Liberati AM, Di Renzo N, Castagna L, Giordano L, Carlo-Stella C.

J Clin Oncol. 2016 Sep 20;34(27):3293-9. doi: 10.1200/JCO.2016.66.4466. Epub 2016 Jul 5.

23.

PO-44 - Tissue factor pathway inhibitor-2 (TFPI-2) is cleaved by PRSS3: implication for tumor endothelial cells migration.

Ghilardi C, Anastasia A, Avigni R, Lupi M, Giavazzi R, Bani MR.

Thromb Res. 2016 Apr;140 Suppl 1:S192-3. doi: 10.1016/S0049-3848(16)30177-3. Epub 2016 Apr 8.

PMID:
27161730
24.

Demographic variables, clinical aspects, and medicolegal implications in a population of patients with adjustment disorder.

Anastasia A, Colletti C, Cuoco V, Quartini A, Urso S, Rinaldi R, Bersani G.

Neuropsychiatr Dis Treat. 2016 Apr 1;12:737-43. doi: 10.2147/NDT.S92637. eCollection 2016.

25.

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

Zinzani PL, Broccoli A, Gioia DM, Castagnoli A, Ciccone G, Evangelista A, Santoro A, Ricardi U, Bonfichi M, Brusamolino E, Rossi G, Anastasia A, Zaja F, Vitolo U, Pavone V, Pulsoni A, Rigacci L, Gaidano G, Stelitano C, Salvi F, Rusconi C, Tani M, Freilone R, Pregno P, Borsatti E, Sacchetti GM, Argnani L, Levis A.

J Clin Oncol. 2016 Apr 20;34(12):1376-85. doi: 10.1200/JCO.2015.63.0699. Epub 2016 Feb 16.

26.

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL).

Balzarotti M, Brusamolino E, Angelucci E, Carella AM, Vitolo U, Russo E, Congiu A, Gotti M, Massidda S, Botto B, Annechini G, Spina M, Re A, Zilioli VR, Merli F, Salvi F, Stelitano C, Bonfichi M, Rodari M, Murru R, Magagnoli M, Anastasia A, Mazza R, Giordano L, Santoro A.

Leuk Lymphoma. 2016 Oct;57(10):2375-81. doi: 10.3109/10428194.2016.1140161. Epub 2016 Feb 15.

PMID:
26879066
27.

Arabidopsis response regulator 22 inhibits cytokinin-regulated gene transcription in vivo.

Wallmeroth N, Anastasia AK, Harter K, Berendzen KW, Mira-Rodado V.

Protoplasma. 2017 Jan;254(1):597-601. doi: 10.1007/s00709-016-0944-4. Epub 2016 Jan 15.

PMID:
26769709
28.

Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.

Luminari S, Galimberti S, Versari A, Biasoli I, Anastasia A, Rusconi C, Ferrari A, Petrini M, Manni M, Federico M.

Haematologica. 2016 Feb;101(2):e66-8. doi: 10.3324/haematol.2015.132811. Epub 2015 Oct 15. No abstract available.

29.

Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma.

Pata G, Damiani E, Bartoli M, Solari S, Anastasia A, Pagani C, Tucci A, Ragni F.

Leuk Lymphoma. 2016;57(6):1467-70. doi: 10.3109/10428194.2015.1092529. Epub 2015 Oct 15. No abstract available.

PMID:
26373930
30.

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.

Tiacci E, Park JH, De Carolis L, Chung SS, Broccoli A, Scott S, Zaja F, Devlin S, Pulsoni A, Chung YR, Cimminiello M, Kim E, Rossi D, Stone RM, Motta G, Saven A, Varettoni M, Altman JK, Anastasia A, Grever MR, Ambrosetti A, Rai KR, Fraticelli V, Lacouture ME, Carella AM, Levine RL, Leoni P, Rambaldi A, Falzetti F, Ascani S, Capponi M, Martelli MP, Park CY, Pileri SA, Rosen N, Foà R, Berger MF, Zinzani PL, Abdel-Wahab O, Falini B, Tallman MS.

N Engl J Med. 2015 Oct 29;373(18):1733-47. doi: 10.1056/NEJMoa1506583. Epub 2015 Sep 9.

31.

Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2.

Ghilardi C, Silini A, Figini S, Anastasia A, Lupi M, Fruscio R, Giavazzi R, Bani MR.

Oncotarget. 2015 Sep 29;6(29):28389-400. doi: 10.18632/oncotarget.4949.

32.

Detection of p75NTR Trimers: Implications for Receptor Stoichiometry and Activation.

Anastasia A, Barker PA, Chao MV, Hempstead BL.

J Neurosci. 2015 Aug 26;35(34):11911-20. doi: 10.1523/JNEUROSCI.0591-15.2015.

33.

A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.

Tedeschi A, Rossi D, Motta M, Quaresmini G, Rossi M, Coscia M, Anastasia A, Rossini F, Cortelezzi A, Nador G, Scarfò L, Cairoli R, Frustaci AM, Dalceggio D, Picardi P, De Paoli L, Orlandi E, Rambaldi A, Massaia M, Gaidano G, Montillo M; Rete Ematologica Lombarda–CLL Workgroup.

Haematologica. 2015 Dec;100(12):e501-4. doi: 10.3324/haematol.2015.132035. Epub 2015 Aug 20. No abstract available.

34.

Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.

Carli M, Kostoula C, Sacchetti G, Mainolfi P, Anastasia A, Villani C, Invernizzi RW.

J Neurochem. 2015 Nov;135(4):674-85. doi: 10.1111/jnc.13280. Epub 2015 Sep 17.

35.

Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder.

D'Urso G, Brunoni AR, Anastasia A, Micillo M, de Bartolomeis A, Mantovani A.

Neurocase. 2016;22(1):60-4. doi: 10.1080/13554794.2015.1045522. Epub 2015 May 14.

PMID:
25971992
36.

Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.

Marcheselli L, Bari A, Anastasia A, Botto B, Puccini B, Dondi A, Carella AM, Alvarez I, Chiarenza A, Arcari A, Salvi F, Federico M.

Br J Haematol. 2015 May;169(4):544-51. doi: 10.1111/bjh.13332. Epub 2015 Mar 29.

PMID:
25817296
37.

[A case of shared psychotic disorder (folie à deux) with original aspects associated with cross-cultural elements].

Cuoco V, Colletti C, Anastasia A, Weisz F, Bersani G.

Riv Psichiatr. 2015 Jan-Feb;50(1):43-6. doi: 10.1708/1794.19538. Italian.

PMID:
25805355
38.

Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice.

Lee BG, Anastasia A, Hempstead BL, Lee FS, Blendy JA.

Nicotine Tob Res. 2015 Dec;17(12):1428-35. doi: 10.1093/ntr/ntv047. Epub 2015 Mar 5.

39.

High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.

Castagna L, Crocchiolo R, Giordano L, Bramanti S, Carlo-Stella C, Sarina B, Chiti A, Mauro E, Gandolfi S, Todisco E, Balzarotti M, Anastasia A, Magagnoli M, Brusamolino E, Santoro A.

Bone Marrow Transplant. 2015 Apr;50(4):499-504. doi: 10.1038/bmt.2014.304. Epub 2015 Jan 26.

PMID:
25621797
40.

Dissociative symptoms in female patients with mood and anxiety disorders: a psychopathological and temperamental investigation.

Bersani G, Moscariello MA, Bersani FS, Colletti C, Anastasia A, Prinzivalli E, Valeriani G, Salviati M.

Eur Rev Med Pharmacol Sci. 2014;18(21):3217-22.

41.

[Socio-demographic, clinical and criminological features of a population discharged from forensic hospital and admitted to neuropsychiatric clinic, in scheme of restriction of freedom].

Anastasia A, Cataldo D, Colletti C, Di Falco R, Centracchio I, Del Nero P, Rinaldi R, Bersani G.

Riv Psichiatr. 2014 Sep-Oct;49(5):235-42. doi: 10.1708/1668.18266. Italian.

PMID:
25424336
42.

Changes in dream experience in relation with antidepressant escitalopram treatment in depressed female patients: a preliminary study.

Quartini A, Anastasia A, Bersani FS, Melcore C, Albano G, Colletti C, Valeriani G, Bersani G.

Riv Psichiatr. 2014 Jul-Aug;49(4):187-91. doi: 10.1708/1600.17460.

PMID:
25174696
43.

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi.

Anastasia A, Carlo-Stella C, Corradini P, Salvi F, Rusconi C, Pulsoni A, Hohaus S, Pregno P, Viviani S, Brusamolino E, Luminari S, Giordano L, Santoro A.

Br J Haematol. 2014 Jul;166(1):140-2. doi: 10.1111/bjh.12821. Epub 2014 Mar 7. No abstract available.

PMID:
24606548
44.

Trkb signaling in pericytes is required for cardiac microvessel stabilization.

Anastasia A, Deinhardt K, Wang S, Martin L, Nichol D, Irmady K, Trinh J, Parada L, Rafii S, Hempstead BL, Kermani P.

PLoS One. 2014 Jan 31;9(1):e87406. doi: 10.1371/journal.pone.0087406. eCollection 2014.

45.

Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction.

Anastasia A, Deinhardt K, Chao MV, Will NE, Irmady K, Lee FS, Hempstead BL, Bracken C.

Nat Commun. 2013;4:2490. doi: 10.1038/ncomms3490. Erratum in: Nat Commun. 2014;5:3564.

46.

BDNF protects human vascular endothelial cells from TNFα-induced apoptosis.

Takeda K, Kermani P, Anastasia A, Obinata Y, Hempstead BL, Kurihara H.

Biochem Cell Biol. 2013 Oct;91(5):341-9. doi: 10.1139/bcb-2013-0005. Epub 2013 Jun 10.

PMID:
24032685
47.

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials.

Zinzani PL, Viviani S, Anastasia A, Vitolo U, Luminari S, Zaja F, Corradini P, Spina M, Brusamolino E, Gianni AM, Santoro A, Botto B, Derenzini E, Pellegrini C, Argnani L.

Haematologica. 2013 Aug;98(8):1232-6. doi: 10.3324/haematol.2012.083048. Epub 2013 May 3.

48.

Comparison of facial expression in patients with obsessive-compulsive disorder and schizophrenia using the Facial Action Coding System: a preliminary study.

Bersani G, Bersani FS, Valeriani G, Robiony M, Anastasia A, Colletti C, Liberati D, Capra E, Quartini A, Polli E.

Neuropsychiatr Dis Treat. 2012;8:537-47. doi: 10.2147/NDT.S37174. Epub 2012 Dec 18.

49.

Premorbid circadian profile of patients with major depression and panic disorder.

Bersani G, Bersani FS, Prinzivalli E, Limpido L, Marconi D, Valeriani G, Colletti C, Anastasia A, Pacitti F.

Riv Psichiatr. 2012 Sep-Oct;47(5):407-12. doi: 10.1708/1175.13031.

PMID:
23160051
50.

[Facial Action Coding System (FACS): an instrument for the objective evaluation of facial expression and its potential applications to the study of schizophrenia].

Polli E, Bersani FS, De Rose C, Liberati D, Valeriani G, Weisz F, Colletti C, Anastasia A, Bersani G.

Riv Psichiatr. 2012 Mar-Apr;47(2):126-38. doi: 10.1708/1069.11717. Review. Italian.

PMID:
22622249

Supplemental Content

Loading ...
Support Center